The pharmaceutical industry is bracing for chaos if President Trump follows through on his threat to impose “a major tariff” ...

Plus: Comcast rolls out small-business assistance; Richie Neal takes Trump to task for tariff policies; Healey rolls out new ...

Treatment consisted of 4-6 cycles of dose-dense intensive chemotherapy incorporating hyperfractionated ...

AstraZeneca PLC closed 22.92% short of its 52-week high of £133.88, which the company reached on September 3rd.

AstraZeneca has been busy in recent years pumping up its oncology pipeline via a shopping list of assets and companies. | ...

As first quarter earnings begin, executives are confronting market turmoil, regulatory instability and the threat of U.S.

Now may be an ideal time to buy stocks. Even if you don't have a lot of money that you can afford to invest, there are many ...

Danuglipron: According to the company's latest statement, one patient experienced a potential liver injury that may have been ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

A new drug that helps slow the spread of an incurable type of breast cancer has been approved for use in Britain's state-run ...

A twice-a-day pill for advanced breast cancer has been approved for use on the NHS. The life-extending drug, called ...

Results from a clinical trial showed that capivasertib plus the hormone therapy fulvestrant increased the time before the ...